Investigation of Predictive Indices to Objectively Guide Choice of CPAP Interface
Selecting the Appropriate CPAP Interface: Investigation of Predictive Indices to Objectively Guide the Choice of Interface
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Obstructive sleep apnea (OSA) is a prevalent disease, and one that is associated with significant negative impact on long-term survival. There is convincing evidence that treatment of OSA can improve outcome in patients with cardiovascular disease, improve blood pressure and blood glucose control, and improve the overall metabolic syndrome. Treatment is usually with continuous positive airway pressure (CPAP). However, many patients face problems with their CPAP interfaces, affecting their compliance and response to treatment. Proper mask fit is important in decreasing air leak and increasing comfort, thus leading to better compliance. Currently, the choice of interfaces depends mainly on the experience of the sleep disorder unit (SDU) technicians. Unsuitable choice of interface not only affects response to treatment but also increases medical costs when interfaces need to be replaced to better fitting ones. It is thus important to develop selection criteria to objectively guide the SDU technicians in choosing the suitable interfaces. The objective of this study is to study the facial profile of patients and look for predictive indices that can be used to objectively guide the choice of appropriate interfaces. Frontal and side profile photographs of patients will be taken and facial measurements will be recorded. Patients will then be given a one monthly trial of each of the 3 interfaces (nasal masks, oronasal masks, nasal cushions) in a randomised order. The patients' subjective perception of each of the interface will be assessed and patients will nominate their preferred interface at the end of the trial. The amount of leak and the hours of adherence for each type of interface will also be analysed. A multinomial logistic regression analysis will then be done to look for facial measurements that will predict the interface that patients will be most satisfied with. Hypothesis That measurement of facial structures and clinical features will be able to predict the best-fit CPAP interface for each patient. Study Objective
- To determine anthropometric facial measurements and clinical factors important in achieving a good interface fit for each patient
- To derive a prediction rule or equation that will be able to accurately predict which interface a patient should be prescribed
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2014
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2017
CompletedFirst Submitted
Initial submission to the registry
February 14, 2017
CompletedFirst Posted
Study publicly available on registry
February 24, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2017
CompletedFebruary 27, 2018
February 1, 2018
2.5 years
February 14, 2017
February 26, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Choice of preferred interface at the end of the one monthly trial of the 3 interfaces
6 month
Secondary Outcomes (4)
Level of satisfaction (assessed with visual analogue scale) with each interface
1 month
Amount of leak for each interface
1 month
Hours of adherence for each interface
1 month
Compliance with the chosen interface at 6 month follow-up
6 month
Study Arms (3)
one month trial of Nasal Mask
OTHERAll patients in study underwent crossover prospective trial of the same 3 types of CPAP interfaces in randomized order. Trial was 1 month duration for each interface.
One month trial of Oronasal mask
OTHERAll patients in study underwent crossover prospective trial of the same 3 types of CPAP interfaces in randomized order. Trial was 1 month duration for each interface.
One month trial of Nasal pillows
OTHERAll patients in study underwent crossover prospective trial of the same 3 types of CPAP interfaces in randomized order. Trial was 1 month duration for each interface.
Interventions
All patients in study underwent crossover prospective trial of the same 3 types of CPAP interfaces (nasal mask, oronasal mask, nasal pillows) in randomized order. Trial was 1 month duration for each interface.
Eligibility Criteria
You may qualify if:
- Patients with OSA of at least moderate severity (Apnea hypopnea index (AHI) score of ≥15 on baseline polysomnography with ESS ≥ 10 or AHI≥30 regardless of ESS).
- Patients with no previous experience with CPAP.
- Patients who are between 21 - 90 year old
You may not qualify if:
- Patients with significant orofacial problems that preclude the use of the interfaces.
- Patients who did not consent to participate in study or are unable to give informed consent.
- Patients with significant underlying cardiorespiratory disease that will preclude the use of AutoPAP mode of ventilation for treatment of OSA.
- Patients who cannot tolerate a 5minute quick trial of the interface during counselling
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Goh KJ, Soh RY, Leow LC, Toh ST, Song PR, Hao Y, Lee KCH, Tan GL, Ong TH. Choosing the right mask for your Asian patient with sleep apnoea: A randomized, crossover trial of CPAP interfaces. Respirology. 2019 Mar;24(3):278-285. doi: 10.1111/resp.13396. Epub 2018 Sep 6.
PMID: 30189465DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Rui Ya Soh
Singhealth Foundation
- PRINCIPAL INVESTIGATOR
Thun How Ong
Singhealth Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2017
First Posted
February 24, 2017
Study Start
August 1, 2014
Primary Completion
January 31, 2017
Study Completion
March 30, 2017
Last Updated
February 27, 2018
Record last verified: 2018-02